To make transplants clinically feasible, this field needs a source of histocompatible, ethically acceptable and non-tumorgenic cells.
Danju Tso, Randall D McKinnon 2015, 'Cell replacement therapy for central nervous system diseases', Neural Regeneration Researchhttp://www.nrronline.org/article.asp?issn=1673-5374;year=2015;volume=10;issue=9;spage=1356;epage=1358;aulast=Tso. Retrieved from DOAJ CC BY 4.0 (https://creativecommons.org/licenses/by-sa/4.0/legalcode)